Hemodilution tolerance in patients with coronary artery disease who are receiving chronic beta-adrenergic blocker therapy

Anesthesia and Analgesia
D R SpahnT Pasch

Abstract

Hemodilution tolerance is not well defined in patients with coronary artery disease receiving beta-adrenergic blockers chronically. Ninety patients scheduled for coronary artery bypass graft (CABG) surgery were randomized to a hemodilution (n = 60) and a control group (n = 30). During midazolam-fentanyl anesthesia, hemodynamic variables, ST segment deviation, and O2 consumption were determined prior to and after 6 and 12 mL/kg isovolemic exchange of blood for 6% hydroxyethyl starch. Hemoglobin decreased from 12.6 +/- 0.2 to 9.9 +/- 0.2 g/dL (mean +/- SEM, P < 0.05). With stable filling pressures, cardiac index increased from 2.05 +/- 0.05 to 2.27 +/- 0.05 L.min-1.m-2(P < 0.05) and O2 extraction from 27.4% +/- 0.6% to 31.2% +/- 0.7% (P < 0.05), resulting in stable O2 consumption. No alterations in ST segments were observed in leads II and V5 during hemodilution. Individual increases in cardiac index and O2 extraction were not linearly related to age and left ventricular (LV) ejection fraction (P = 0.841, P = 0.799). We conclude that isovolemic hemodilution to a hemoglobin value of 9.9 +/- 0.2 g/dL is well tolerated and fully compensated in patients with coronary artery disease receiving beta-adrenergic blockers chronically. With...Continue Reading

References

Nov 1, 1992·Anesthesia and Analgesia·B J Leone, D R Spahn
Feb 1, 1991·Journal of Cardiothoracic and Vascular Anesthesia·T ShinodaF G Estafanous
Sep 1, 1991·Stroke; a Journal of Cerebral Circulation·A Shahar, M Sadeh
Jan 1, 1990·Anesthesiology·D T Mangano
Aug 1, 1989·Anesthesia and Analgesia·S MourenP Viars
Jan 1, 1985·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·R Vara-Thorbeck, J A Guerrero-Fernandez Marcote
Oct 1, 1981·Acta Anaesthesiologica Scandinavica·B Roseberg, K Wulff
Sep 1, 1981·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·C K Chapler, S M Cain
Mar 16, 1995·The New England Journal of Medicine·C J Rutherford, H S Kaplan

❮ Previous
Next ❯

Citations

Dec 23, 2004·Der Anaesthesist·C MadjdpourD R Spahn
Aug 11, 2005·Der Anaesthesist·O Habler
Apr 13, 2007·Der Urologe. Ausg. A·O HablerB Zwissler
Jun 1, 2005·Anesthesiology Clinics of North America·Mercy Kuriyan, Jeffrey L Carson
Jun 1, 2005·Anesthesiology Clinics of North America·Terri G Monk
Aug 5, 1997·Transfusion Science·O P Habler, K F Messmer
Aug 5, 1997·Transfusion Science·M Haller, H Forst
Apr 22, 2003·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·Miomir-D JovićBosko P Ethukanović
Feb 17, 2009·British Journal of Anaesthesia·R D SlightP S Mankad
Mar 14, 2001·Critical Care Medicine·P C HébertUNKNOWN Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group
Oct 11, 2005·Critical Care Medicine·O Habler
Apr 18, 2006·Critical Care Medicine·Caveh MadjdpourRichard B Weiskopf
Mar 6, 2003·Vox Sanguinis·Paul C Hébert, UNKNOWN Transfusion Requirements in Critical Care
Mar 20, 2010·Critical Care : the Official Journal of the Critical Care Forum·Benoit ValletGilles Lebuffe
Jun 25, 1998·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·O HablerK Messmer
Dec 6, 2008·Transfusion Medicine Reviews·Robert D SlightPankaj S Mankad
May 28, 2008·Journal of Cardiothoracic and Vascular Anesthesia·Paul G LoubserAryeh Shander
May 23, 2008·Best Practice & Research. Clinical Anaesthesiology·Roman Kocian, Donat R Spahn
Aug 7, 2007·Lancet·Harvey G KleinJeffrey L Carson
Jul 27, 2007·Best Practice & Research. Clinical Anaesthesiology·Caveh Madjdpour, Donat R Spahn
Jul 27, 2007·Best Practice & Research. Clinical Anaesthesiology·Benoit ValletGilles Lebuffe
Jun 7, 2003·Transfusion Medicine·B CarvalhoR J Telford
Oct 6, 2004·Best Practice & Research. Clinical Anaesthesiology·Donat R Spahn
May 12, 2004·Critical Care Clinics·Donat R SpahnPierre-Guy Chassot
Aug 12, 2009·The Medical Clinics of North America·Manish S Patel, Jeffrey L Carson
May 12, 2004·Critical Care Clinics·Paul C HébertLing Qun Hu
Oct 3, 2006·Current Opinion in Anaesthesiology·D R Spahn, T Pasch
Apr 24, 2004·Transfusion·Jodi B SegalEliseo Guallar
Jun 1, 2001·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Jean-François Hardy, Sylvain Bélisle
Jan 1, 1997·Hematology·L T GoodnoughT G Monk
Feb 1, 2003·Transfusion·Richard B WeiskopfPearl Toy
Jun 22, 2000·Anesthesiology·D R Spahn, M Casutt
Oct 3, 2002·Anesthesiology·Richard B Weiskopf
Oct 31, 2001·Anesthesiology·J van BommelC P Henny
Mar 22, 2006·Anaesthesia·T A Etchells, M J Harrison

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.